SCHEMBL19675708

SCHEMBL19675708

CCC(=O)C1CC(=O)N(c2ccccc2)C1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.60
CASP1 P29466 1/20 0.56
CASP7 P55210 1/20 0.56
TSHR P16473 4/20 0.55
USP2 O75604 1/20 0.55
TP53 P04637 1/20 0.55
ALDH1A1 P00352 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HPGD P15428 1/20 0.53
MAPT P10636 2/20 0.53
PKM P14618 1/20 0.53
MAPK1 P28482 1/20 0.53
POLB P06746 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13803643 0.83 ALDH1A1 (0.58) NPC1CASP1CASP7TSHRALDH1A1
SCHEMBL20116495 0.82 CA12 (0.66) NPC1CASP1CASP7TSHRALDH1A1
SCHEMBL892508 0.82 CA12 (0.66) NPC1CASP1CASP7TSHRALDH1A1
SCHEMBL12668076 0.81 HPGD (0.70) NPC1TSHRUSP2TP53ALDH1A1
SCHEMBL10202314 0.81 TSHR (0.71) NPC1TSHRUSP2ALDH1A1L3MBTL1
SCHEMBL16131376 0.80 RAB9A (0.60) NPC1TSHRALDH1A1L3MBTL1MEN1
SCHEMBL20116623 0.80 ALDH1A1 (0.58) NPC1TSHRALDH1A1L3MBTL1MEN1
SCHEMBL14817520 0.79 TSHR (0.76) TSHRALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17321490 0.79 ALDH1A1 (0.54) NPC1CASP1CASP7TSHRUSP2
SCHEMBL892079 0.79 ALDH1A1 (0.67) NPC1TSHRUSP2TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9926282-B2 Phthalazinones and isoquinolinones as rock inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-27 US disclosed
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 EP disclosed